2 min read

David Price throws at a workout in Fort Myers, Fla., Sunday. AP NEWSWIRE
David Price throws at a workout in Fort Myers, Fla., Sunday. AP NEWSWIRE
FORT MYERS, Fla. (AP) — Boston Red Sox ace David Price says it’s still too early to tell when his ailing left elbow and forearm will heal enough for him to pitch in a game.

Price was told this week that he won’t need surgery or an injection. The team said he will be shut down for seven to 10 days, take anti-inflammatory medicine and be re-evaluated after that.

“I’m not going to put a timetable on it,” Price said Saturday. “If it doesn’t get better in a certain time period, it’s something we’re going to have to talk about again.” 

Price got the news on Friday, after meeting with noted orthopedists James Andrews and Neal ElAttrache in Indianapolis, where the doctors were taking part in the NFL Combine.

It was welcome news for the Red Sox, who are counting on Price to be one of their big trio of starting pitchers, along with 2016 Cy Young winner Rick Porcello and left-hander Chris Sale, acquired in a December trade with the White Sox for four top prospects.

Advertisement

The 31-year-old Price felt discomfort on Wednesday morning, a day after throwing a two-inning, 38-pitch simulated game. He was scratched from his first scheduled Grapefruit League start, Sunday against the Braves.

Price is entering his 10th major league season. He wouldn’t say whether he expects to pitch in a spring training game or whether he thought he would be ready by opening day.

Red Sox manager John Farrell said the diagnosis was “probably the best-case scenario that could have come out of the exam.”

Dombrowski didn’t speculate on whether Price is likely to start the season on the disabled list.

“We haven’t even discussed that,” Dombrowski said. “We’ve been careful not to get into that. That’s not the most important part. The most important part is to get him throwing again.”

Price went 17-9 with a 3.99 ERA in a major league-leading 35 starts last season, his first in Boston. 


Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.